Fibroblast growth factors (FGFs) 11±14 comprise a subfamily of FGFs with poorly de®ned biological function. Here we characterize two isoforms of FGF14 (FGF14-1a and FGF14-1b) that result from the alternative usage of two different ®rst exons. We demonstrate that these isoforms have differential subcellular localization and that they are differentially expressed in various adult tissues. Using in situ hybridization we show that Fgf14 is widely expressed in brain, spinal cord, major arteries and thymus between 12.5 and 14.5 days of mouse embryonic development. We also show that during cerebellar development, Fgf14 is ®rst observed at postnatal day 1 in post mitotic granule cells, and later in development, in migrating and post migratory granule cells. The developmental expression pattern of Fgf14 in the cerebellum is complementary to that of Math1, a marker for proliferating granule cells in the external germinal layer. q
Introduction and results
Fibroblast growth factors (FGFs) 11±14 were recently identi®ed as FGF homologous factors (FHFs) based on sequence comparison with other members of the FGF family (Smallwood et al., 1996; Hartung et al., 1997) . The FHFs appear to constitute a distinct subgroup of the FGF family because they show 58 to 71 percent amino acid sequence identity with each other but less than 30 percent identity with other FGFs. Nevertheless, FGFs 11-14 and all other FGFs share 7 identical and 18 homologous amino acid residues in the core region .
Two isoforms of FGF14, FGF14-1a and FGF14-1b, were cloned by 5 H RACE. FGF14-1a and FGF14-1b differ only in the ®rst , 70 N-terminal amino acids (Fig. 1A) suggesting that they are generated by alternative usage of 2 different ®rst exons. Sequence analysis identi®ed three clusters of basic residues in FGF14-1a that are highly homologous to the corresponding regions of FGF12 (Fig. 1A) . The proximal two clusters (1 and 2 in Fig. 1A ) are essential for the nuclear localization of FGF12 (Smallwood et al., 1996) . In contrast, FGF14-1b lacks nuclear targeting sequences suggesting that the two isoforms of FGF14 may have distinct subcellular localization. To test this hypothesis, the subcellular localization of FGF14-1a and FGF14-1b was assayed in NIH3T3 cells by expressing a FGF14-GFP fusion protein. FGF14-1a-GFP was predominantly localized in the nucleus while FGF14-1b-GFP was localized in the cytoplasm (Fig. 1B) .
The relative expression levels of the two isoforms of Fgf14 in adult mouse tissues were examined using a splice-form-speci®c RNase protection probe (Fig. 1C) . Tissues examined included brain, thymus, heart, lung, liver, spleen, kidney, testis, small intestine, skeletal muscle and skin. The highest expression was found in brain with Fgf14-1b as the predominant form. Interestingly, the thymus only expressed the Fgf14-1a nuclear isoform at relatively high levels, while testis expressed the Fgf14-1b isoform. Heart expressed very low levels of both isoforms, small intestine expressed low levels of Fgf14-1a and the other tissues examined had no detectable signal.
The developmental expression of Fgf14 was analyzed in mouse embryo sections from E10.5 to E16.5. At E10.5, the expression of Fgf14 was undetectable (data not shown). Fgf14 expression became detectable at E12.5 ( Fig. 2A,B) and was expressed at a higher level by E14.5 (Fig. 2C±P) . The major expression domains of Fgf14 included ventral regions of the developing brain, spinal cord, thymus, aorta and major arteries. In the brain at E12.5 ( Fig. 2A,B ), Fgf14 (99)00241-5 www.elsevier.com/locate/modo was expressed in the supraoptic area, septal area, thylamus, and the ventral lining of the Aqueduct of Sylvius and the forth ventricle. The brain regions that were positive for Fgf14 expression appeared to lie just beneath the neuroepithelium at this stage. At E14.5, Fgf14 expression in the brain persisted at higher levels in every domain found at E12.5. Fgf14 expression domains became broader and more intense in the thickened regions of the subventricular zone adjacent to the neuroepithelium (which contain neurons and glia that are migrating away from the neuroepithelium) and in the pons, medulla oblongata and hypothalamus (Fig. 2C,D and Fig. 3 ). Transverse section through the spinal cord at E14.5 (Fig. 2I,J) showed Fgf14 expression in an apparent ventral to dorsal gradient with Fgf14 expression excluded from the dorsal-most region and the ventricular zones. In summary, the striking characteristic of Fgf14 expression in the CNS is that it is excluded from the neuroepithelium but is expressed in zones that contain migrating neurons and glia.
In both sagittal and transverse sections of E14.5 embryos (Fig. 2E ,F,M±P), Fgf14 was expressed at high levels in the aortic arch, ascending and descending aorta, pulmonary artery, and common carotid artery. At both E12.5 and E14.5 ( Fig. 2A,B ,E,F), high levels of Fgf14 expression were also observed in the thymus. By E16.5 the expression of Fgf14 is down regulated to below detectable levels in all tissues with the exception of the thymus (data not shown).
In situ hybridization and RNase protection studies demonstrated that Fgf14 is highly expressed in the adult cerebellum (Smallwood et al., 1996) . The ontogeny of Fgf14 expression was examined by in situ hybridization throughout cerebellar development. Math1 was used as a marker for the proliferating granule cell population in the external germinal layer (EGL) (Akazawa et al., 1995; Helms and Johnson, 1998) . In the mouse, the cerebellar primordium emerges from the dorsal neural tube just anterior to the fourth ventricle at about embryonic day 10. Granule cells are speci®ed around E13, originate in the rhombic lip and migrate to the surface of the cerebellar primordium forming the external germinal layer (EGL). Granule cells undergo rapid proliferation after birth and the EGL expands to a thickness of eight cells. By postnatal day 4, granule cells located in the inner layer of the EGL stop proliferation and begin to migrate inwardly along Bergmann glia, eventually forming the internal granule layer (IGL) of the mature cerebellum. The migration of granule cells is completed at about postnatal day 25 (Hatten et al., 1997) . Fgf14 and Math1 expression were therefore examined between E12.5 and postnatal day 30 (Fig. 4) .
At E12.5, Fgf14 was expressed in the subventricular zone around the fourth ventricle but not in the dorsal edges where Math1 is highly expressed. At E16.5, the cerebellar primordium is surround by the thin external germinal layer (EGL). Fgf14 was not expressed in the EGL between E16.5 and birth, whereas Math1 was intensely expressed in the EGL at these stages. At postnatal day1, a weak Fgf14 signal was detected in the innermost layer of the EGL. At postnatal day 4 (Fig. 4A,B) , Fgf14 was expressed in deep regions of EGL (which contains differentiating granule cells), in migrating granule cells, and in the IGL (which contains mature granule cells). In contrast, Math1 is only expressed in the outer layer of EGL (which contains proliferating granule cells). By postnatal day16, with the formation of the IGL, Fgf14 was expressed robustly and was maintained in the IGL into adulthood. In contrast to Fgf14, Math1 expression was downregulated as granule cells exited the EGL and was not expressed in the adult.
Materials and methods

cDNA cloning
PCR primers DM78 (CAC WCC WGA RTG CAA ATT CAA RGA) and DO238 (GAA CTT TTT ACC CCT GAA TG) were designed to amplify a predicted exon based on the published human Fgf14 sequence. The PCR products were ligated into the pGEM-T vector (Promega Inc.) and sequenced. The cloned DNA fragment was then used to probe a Balb/c mouse brain cDNA library. Partial cDNA clones revealed the possibility of 2 alternative 5 H ends. Fgf14 expression between E12.5 (A and B) and E14.5 (C-P) of mouse embryonic development. A-F and K-L are sagittal sections. G-J and M-P are transverse sections. aa, aorta arteries; ca, common carotid artery; da, descending aorta; fp,¯oor plate; h, heart; ht, hypothalamus; III, third ventricle; IV, fourth ventricle; m, medulla oblongata; pa, pulmonary artery; p, pons; sa, septal area; sc, spinal cord; t, thymus; th, thylamus; ve, vertebral column.
Rapid ampli®cation of 5
H -cDNA ends (5 H -RACE) 5 H -RACE was carried out using mouse brain cDNA (Clontech Inc.) as a template according to manufacturer's protocol. The nesting primers were DM165 (CCG TT CTG ACG GAT CAA GCC GC) for Fgf14-1b and DM166 (CCA CAA AGA CAC TGC AGC ATA TGC G) for Fgf14-1a.
RNase protection assay (RPA)
A 455 bp probe was generated by PCR using the cloned cDNA as a template to synthesize an RPA probe. rpL32, a control probe that hybridizes to the ribosomal protein L32 message (197 bp) fragment, was also included in the experiment. Tissue RNAs were prepared from adult FVB/N mice. 50 mg of total RNA was incubated with labeled probe for 14 h at 508C, digested with RNaseA and T1 and run on 5% denaturing polyacrylamide gel.
Construction of FGF14-GFP fusion proteins and transfection of NIH3T3 cells
The mouse FGF14 cDNA was ampli®ed by PCR using the oligos QW123 (AGA TCT CCA CCA TGG CCG CGG CCA TCG CCA GCG G) and QW125 (GGA TCC CTT GTG GTC TTG CAC TTG TTG) for FGF14-1a, and QW124 (ACA TCT CCA CCA TGG TAA AAC CGG TGC CCC TCT TC) and QW126 (GGA TCC CTT GTT GTC TTA CTC TTG TTG AC) for Fgf14-1b. PCR products were ligated in to the pGEM-Tvector (Promega Inc.) and sequenced. The correct plasmids were digested with BglII and BamHI and cloned into the pEGFP-N1 vector (Clontech Inc.). The plasmids, named FHF14-1a-GFP and FGF14-1b-
